| 臺大學術典藏 |
2021-03-09T06:46:16Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M.;Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Sheen T.-S.;Lou P.-J.; Hsu M.-M.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Sheen T.-S.; Lou P.-J. |
| 臺大學術典藏 |
2021-03-09T06:46:15Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Hsu M.-M.;Sheen T.-S.;Lou P.-J.;Wang C.-C.;Chung N.-N.;Lui L.T.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Hsu M.-M.; Sheen T.-S.; Lou P.-J.; Wang C.-C.; Chung N.-N.; Lui L.T. |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35
|
Chie W.-C.;Ruey-Long Hong;Lai C.-C.;Ting L.-L.;Hsu M.-M.; Chie W.-C.; RUEY-LONG HONG; Lai C.-C.; Ting L.-L.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:12Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Ruey-Long Hong;Lin C.-Y.;Ting L.-L.;Ko J.-Y.;Hsu M.-M.; RUEY-LONG HONG; Lin C.-Y.; Ting L.-L.; Ko J.-Y.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
|
Chan A.T.C.;Hsu M.-M.;Goh B.C.;Hui E.P.;Liu T.-W.;Millward M.J.;Ruey-Long Hong;Whang-Peng J.;Ma B.B.Y.;To K.F.;Mueser M.;Amellal N.;Lin X.;Chang A.Y.; Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. |
| 臺大學術典藏 |
2021-02-02T08:29:56Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; BOR-RU LIN; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:22:37Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:47:06Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Yeong-Shiau Pu;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Hsieh C.-Y.; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; YEONG-SHIAU PU; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-11-27T08:15:04Z |
Antibodies to Epstein?Barr virus?specific DNase in patients with nasopharyngeal carcinoma and control groups
|
Hu C.?P.; Yang C.?S.; CHANG-YAO HSIEH; Lai M.?Y.; Kuo S.?L.; Chen J.?Y.;Chen C.?J.;Liu M.?Y.;Cho S.?M.;Hsu M.?M.;Lynn T.?C.;Shieh T.;Tu S.?M.;Lee H.?H.;Kuo S.?L.;Lai M.?Y.;Chang-Yao Hsieh;Hu C.?P.;Yang C.?S.; Chen J.?Y.; Chen C.?J.; Liu M.?Y.; Cho S.?M.; Hsu M.?M.; Lynn T.?C.; Shieh T.; Tu S.?M.; Lee H.?H. |
| 臺大學術典藏 |
2020-11-27T08:14:40Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.;Hsu C.-H.;Lin J.-K.;Hsu M.-M.;Ho Y.-F.;She T.-S.;Ko J.-Y.;Lin J.-T.;Lin B.-R.;Wu M.-S.;Yu H.-S.;Jee S.-H.;Chen G.-S.;Chen T.-M.;Chen C.-A.;Lai M.-K.;Pu Y.-S.;Pan M.-H.;Wang Y.-J.;Tsai C.-C.;Chang-Yao Hsieh; Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; CHANG-YAO HSIEH |
